Decision letter for "Efficacy and Safety of Adding a Fourth Oral Antidiabetic Drug Versus Metformin Dose Escalation in Patients with Type 2 Diabetes Inadequately Controlled on Triple Oral Combination Therapy (EFFORT): A 24-Week, Randomized, Open-Label, Multicenter Trial"
Fields of Study & Subjects
Diabetes Treatment and Management
Diabetes Management and Research
Diabetes
Cardiovascular Risks
and Lipoproteins
Publication details
- Publication date
- 22 January 2026